Fundz

MindMaze Therapeutics secures CHF 4.0 million in initial tranche of Neuro.io equity financing, supporting U.S. commercial priorities and neurotherapeutics platform.

PUBLIC · MMTZFAug 10, 2026

Amount Raised

CHF4 Million

Round Type

Venture

GenevaBiotechnologyHealth CareArtificial IntelligenceMedical

Investors

Neuro.Io Group SA

Description

MindMaze Therapeutics has completed the initial tranche of its CHF 8.0 million strategic equity financing with Neuro.io, receiving CHF 4.0 million in gross cash proceeds. In connection with this tranche, 4,970,000 treasury shares were transferred to Neuro.io. The company has revised the funding schedule for the second tranche of CHF 4.0 million. These actions aim to bolster its operations focused on neurology.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as MindMaze Therapeutics Holding SA that raised within 45 days of this round, from Fundz verified event records.

  • Redefine Surgery raised $10M (Pre-Seed) on September 24, 2026.
  • SenseTime MedTech raised $100M (Series B) on September 24, 2026.
  • UltraSight raised $24M (Series B) on September 23, 2026.
  • Cascader raised an undisclosed amount (Seed) on September 23, 2026.
  • Big Picture Bio raised $2M (Pre-Seed) on September 18, 2026.
  • ImpriMed raised $10M (Series A) on September 18, 2026.

Who to call at MindMaze Therapeutics Holding SA, and when

A new round usually means MindMaze Therapeutics Holding SA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MindMaze Therapeutics Holding SA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MindMaze Therapeutics Holding SA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MindMaze Therapeutics Holding SA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MindMaze Therapeutics Holding SA

Location

Geneva, Geneva, Switzerland

About

MindMaze Therapeutics is a global leader in brain technology, dedicated to redefining the recovery trajectory for patients with neurological platform-based digital treatments. By integrating advanced software, proprietary sensors, and AI-driven data analytics, MindMaze Therapeutics provides a seamless continuum of care. The Company's FDA-cleared neurotherapeutics address the systemic shortage of specialized clinicians.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MindMaze Therapeutics Holding SA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsGangadhar G., Director Corporate Development & Strate… hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MindMaze Therapeutics Holding SA's next move

See what Strategic adds

MindMaze Therapeutics Holding SA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.